What We're Reading: Page 339
Industry reads hand-picked by our editors
May 25, 2016
-
Wall Street Journal
SEC Reviewed Valeant’s Use of ‘Non-GAAP’ Financial Measures
-
Reuters
Lilly says new type of pain drug could lessen need for opioids
-
Economic Times
Delhi High Court asks Roche to explain lawsuit over Avastin copy
-
Stat
There’s just one female CEO among San Diego’s public biotechs. Here’s why
May 24, 2016
-
Regulatory Focus
Republican Senators Lobby FDA Ahead of Decision on Sarepta’s DMD Drug
-
Reuters
UCB faces U.S. patent challenge for epilepsy drug
-
In the Pipeline
Trouble at Santa Cruz Biotechnology
-
San Francisco Business Journal
Another Genentech? These are the most likely companies
May 23, 2016
-
Triangle Business Journal
BioPharma Index: CEOs less confident in deal-making environment
-
Quartz
It’s a ‘psychedelic renaissance,’ as scientists identify medicinal qualities of hardcore drugs
-
The Associated Press
France to tighten up drug trial rules after fatal incident
-
PharmExec.com
Biopharma supports nearly 45 million US jobs, says report
May 20, 2016
May 19, 2016
-
Forbes
'Pay For Performance' Drug Plans Could Impact Biopharma's R&D Priorities
-
Reuters
Industry hits back at idea of pharma levy in superbug fight
-
Stat
As takeover talks drag on, Baxalta staff find themselves in merger limbo
-
Bloomberg Businessweek
The Real Reason Big Pharma Wants to Help Pay for Your Prescription
May 18, 2016
-
Reuters
Pascal Soriot's big experiment: reinventing AstraZeneca
-
Bloomberg
Valeant Said to Weigh Sale of Skin, Cancer Drugs to Cut Debt
-
Kaiser Health News
Three Firms Vie To Run CalPERS’ Drug Benefits
-
New York Times
Dogs Test Drug Aimed at Humans' Biggest Killer: Age
May 17, 2016
-
New York Times
Pfizer Could Get Its Money's Worth Out of Anacor Deal
-
Stat
Drug makers fuming at ‘overpriced’ values placed on their myeloma drugs
-
Forbes
Valeant Pharmaceuticals Hands Out Million Dollar Bonuses As Compensation For 'Challenging Times'
-
Reuters
Faced with shortages, Egypt lifts cheap drug prices by 20 percent
Previous
